D-0364-2025 Class II Ongoing
FDA drug recall D-0364-2025 was initiated by Direct Rx on Jan 31, 2025 and is designated Class II. Reason for recall: Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle The recall status is ongoing. Affected quantity: 477 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 23, 2025
- Initiation Date
- Jan 31, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 477 bottles.
Product description
CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.
Reason for recall
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Distribution pattern
Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID
Code information
Lot 11SE2402, Exp Date: 11/30/2025 Lot 14NO2406, Exp Date: 12/31/2025 Lot 29OC2420, Exp Date: 11/30/2025 Lot 30SE2412, Exp Date: 11/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0364-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026